CN107058593A - A kind of hypotype Ph likeALL detection method - Google Patents

A kind of hypotype Ph likeALL detection method Download PDF

Info

Publication number
CN107058593A
CN107058593A CN201710462205.5A CN201710462205A CN107058593A CN 107058593 A CN107058593 A CN 107058593A CN 201710462205 A CN201710462205 A CN 201710462205A CN 107058593 A CN107058593 A CN 107058593A
Authority
CN
China
Prior art keywords
likeall
detection method
hypotype
solution
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710462205.5A
Other languages
Chinese (zh)
Inventor
李彪
李一彪
潘美玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujian Wanke Pharmaceutical Co Ltd
Original Assignee
Fujian Wanke Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujian Wanke Pharmaceutical Co Ltd filed Critical Fujian Wanke Pharmaceutical Co Ltd
Priority to CN201710462205.5A priority Critical patent/CN107058593A/en
Publication of CN107058593A publication Critical patent/CN107058593A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6841In situ hybridisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Abstract

The invention discloses a kind of hypotype Ph likeALL detection method, comprise the following steps:1)Ethanol solution, pretreatment fluid, washing lotion and enzyme buffer liquid are prepared respectively;2)Fluorescence probe dissolves;3)Bone marrow cell is solidified, smear is made;4)By probe solution pre-temperature to room temperature, centrifugation is added drop-wise to hybridising region, sealed;5)Denaturation hybridization;6)Mounting glue is removed, Kao Pulin cylinder wash-ins is placed in and removes cover glass, take out smear, is rinsed with washing lotion, ethanol solution, lucifuge is air-dried;7)Redye;8)Scanning, determines whether sample has heterogeneity.This detection method have the advantages that simply, quick, cost is low, sensitivity is high, high specificity, detects comprehensive, being capable of simple and quick comprehensively detection Ph likeALL.

Description

A kind of hypotype Ph-likeALL detection method
Technical field
The present invention relates to biology field, and in particular to a kind of hypotype Ph-likeALL detection method.
Background technology
ALL(Abbreviation ALL)It is the most common tumour of children, the incidence of disease drops with the growth at age Low, current reappearance chromosomal change is ALL important symbol, including Chromosome recombination, structural change etc..For many years, it is clinical By combining above-mentioned chromosomal variation feature, risk stratification treatment is carried out to ALL so that ALL therapeutic effect has obtained very big It must improve, wherein the 5 of children ALL year survival rate has brought up to 85%, but still there are some patientss to treat poor prognosis, ALL's answers Send out intractable and cause the disease to be still one of main fatal disease of children and adults.
Ph-likeALL, is the one group of disease identified according to gene expression profile, and its gene expression profile is positive with BCR-ABL1 ALL is similar, but does not express BCR-ABL1, so referred to as BCR-ABL1-like ALL, also known as Ph-likeALL.Such ALL It is mainly seen in acute precursor B cells lymphocytic leukemia(BCP- ALL), typically lack typical gene and dye in BCP-ALL Colour solid makes a variation(ETV6-RUNX1, E2A-PBX1, ERG and MLL rearrangement, hyperdiploid etc.)And it is often clinical special with excessive risk Levy.Research finds that Ph-likeALL accounts for SR(Mark danger)And HR(It is high-risk)The 15% of children B-ALL, in young ALL about 27.4%.Similar to BCR-ABL1 positives ALL, Ph-likeALL patient's poor prognosis, conventional chemotherapy effect is not good, easily recurrence.Cell ABL1, ABL2, CSF1R and the PDGFRB fusion that strain and human leukaemia cell express are in vitro to Dasatinib (dasatinib)Sensitivity, EPOR and JAK2 replace Buddhist nun to phosphoric acid Luso(ruxolitinib)Sensitivity, ETV6-NTRK3 fusions Buddhist nun is replaced to gram azoles(crizotinib)It is sensitive.Said medicine plays inhibitory action only for indivedual abnormal fusions, uses There is certain limitation;In detection or cell processes, it is necessary to which multi-medicament repeated detection, cumbersome.
The content of the invention
The technical problems to be solved by the invention are to overcome the defect of above prior art there is provided a kind of hypotype Ph- LikeALL detection method, simple and quick can comprehensively detect Ph-likeALL.
The technical scheme is that:A kind of hypotype Ph-likeALL detection method, comprises the following steps:
1)Ethanol solution, pretreatment fluid, washing lotion and enzyme buffer liquid are prepared respectively, put 2 DEG C of -8 DEG C of condition of nitrogen gas storages;
2)Fluorescence probe dissolves:Jia 10 into probe tube ~ 20 μ l water, add 150 ~ 200 μ l hybridization solutions, 30 ~ 60s of ultrasonic dissolution, Obtain probe solution;
3)Bone marrow cell is solidified, is applied on slide, by pretreatment, smear is made;It is described be cured as test tube of hepari processing or Handled through EDTA- sodium acetates;
4)By probe solution pre-temperature to room temperature, whirlpool is mixed, and centrifuges 2 ~ 3s, and the probe solution for taking 5 ~ 15 μ l to mix is added drop-wise to hybridization Region, covered is sealed with mounting glue;
5)Setting program:First 70 ~ 80 DEG C are denatured 5 ~ 10 minutes, and then 35 ~ 40 DEG C hybridize 16 ~ 18h;
6)Mounting glue is removed, 1 ~ 5min washes away cover glass in the room temperature washing lotion being placed in Kao Pulin cylinders, take out smear, with warmed-up 1 ~ 3min is rinsed to 72 ~ 74 DEG C of washing lotions, then 1 ~ 3min, lucifuge natural air drying are rinsed with the ethanol solution of room temperature 65 ~ 75%;
7)Dropwise addition redyes liquid to hybridising region, and covered is put -25 ~ -15 DEG C of dark places and redyed more than 20 minutes;It is described to redye Liquid is made up of the component of following parts by weight:5 ~ 7 parts of gram staining liquid, 1 ~ 3 part of magnesium chloride, 0.2 ~ 0.6 part of citric acid, fluorescence 0.5 ~ 0.7 part of element, 0.1 ~ 0.3 part of sodium alginate;
8)Sample is scanned using object lens, determines whether sample has heterogeneity.
Specifically, the volume fraction of the ethanol solution is 70 ~ 85%;The pretreatment fluid is 0.9 ~ 1.1mol/L sulphur Cyanic acid sodium solution;The washing lotion is made up of the component of following percetage by weight:Sodium chloride 1.7 ~ 1.8%, sodium citrate 0.8 ~ 1%, Nonidet P40 0.2 ~ 0.4%, surplus is water;The enzyme buffer liquid is 0.009 ~ 0.011mol/L watery hydrochloric acid.
Preferably, totally 12 groups of the fluorescence probe, respectively ABL1, ABL2, CSF1R, PDGFRB, CRLF2, JAK2, EPOR, IL2RB, NTRK3, PTK2B, TSLP and TYK2.
Most Ph-likeALL patients have chromosomal rearrangement or other hereditary changes, can active cell factor acceptor Or kinase signal.Rearranged gene includes ABL1, ABL2, CRLF2, CSF1R, EPOR, JAK2, NTRK3, PDGFRB, PTK2B, IL2RB, TSLP or TYK2.ABL1, ABL2, CSF1R, JAK2 are expressed and PDGFRB fusions cause cell factor Independence is expanded and phosphorylation STAT5 activation.Above-mentioned rearranged gene is marked and obtains fluorescence probe, examination is made with redying liquid Agent box.
Redye liquid to add after denaturation hybridization, its effect embodies during redying and observing.Redye liquid and use gram Dyeing liquor is main component, and fluorescein increase fluorescent effect, addition magnesium chloride can increase the mark color developing effect of fluorescence probe;Sea Mosanom contributes to cell to be uniformly dispersed and redye, and citric acid then accelerates the fusion process of abnormal cell, and cell is dispersed During redying, abnormal cell is rapidly merged each other.Mutually effectively cooperation can be quickly and accurately for each component in a word Whether observation sample has the opposite sex.Fluorescence probe enumerate be currently known targetedly medication Ph-likeALL types, warp Probe solution is with after denaturing samples hybridization, being added dropwise and redying liquid, can all-sidedly and accurately detect Ph-likeALL.
Preferably, the step 2)Fluorescence probe dissolving also comprises the following steps:With liquid-transfering gun rinse probe bottom of the tube and Tube wall, vibration mixes 20 ~ 40s, centrifuges 20 ~ 40s, puts 35 ~ 40 DEG C of water-bath insulations and dissolves 5 ~ 15 minutes;Repeat said process 2 ~ 3 It is secondary, by the probe solution prepared it is standby or packing frost be kept in dark place.
Preferably, the step 6)Kao Pulin cylinders are additionally operable to hold pretreatment fluid, washing lotion and enzyme buffer liquid, by the washing lotion 72 ~ 74 DEG C are preheated to, the pretreatment fluid is preheated to 75 ~ 85 DEG C, the enzyme buffer liquid is preheated to 36 ~ 38 DEG C.
Preferably, the pH value of the washing lotion at room temperature is 7.0 ± 0.2;The enzyme buffer liquid is 0.01mol/L dilute salt Acid, pH value at room temperature is 2.0 ± 0.2.
Specifically, the step 3)Pretreatment comprises the following steps:a)By 60 ~ 70 DEG C of 5 ~ 10min of preheating of smear, waxdip is used The transparent liquid that dewaxes is dewaxed 2 10 ~ 20min every time, and 23 ~ 5min every time are dehydrated with absolute ethyl alcohol;b)Successively in 85% ethanol, 70% Gradient rehydration in ethanol, purified water, each 0.5 ~ 2min sucks residual solution;c)It is placed on and has been preheated with 75 ~ 85 DEG C of pretreatment 20 ~ 40min is incubated in liquid, takes out and 1 ~ 2min is soaked in purified water, suck residual solution;d)40 ~ 60mg pepsins are taken to do Powder, which is dissolved in, to be pre-heated in 36 ~ 38 DEG C of enzyme buffer liquid, 20 ~ 30min of immersion digestion;e)1 ~ 2min is soaked in purified water, Serial dehydration, each 0.5 ~ 2min, drying for standby in 85% ethanol, 70% ethanol, purified water successively.
Preferably, the step a)Waxdip dewaxing transparent liquid is isoparaffin type
Preferably, the step c)Described in pretreatment fluid be 0.9 ~ 1.1mol/L sodium thiocyanate solution.
Preferably, the enzyme buffer liquid is 0.01mol/L watery hydrochloric acid, and pH value at room temperature is 2.0 ± 0.2.
Preferably, there is the feature of heterogeneity in the result of the scanning to have fused cell.
The beneficial effects of the invention are as follows:
1) this detection method have the advantages that simply, quick, cost is low, sensitivity is high, high specificity, detects comprehensive, Neng Goujian It is single quickly comprehensively to detect Ph-likeALL;
2) fluorescence probe enumerate be currently known targetedly medication Ph-likeALL types, comprehensively detection can be Clinical guidance medication provides favourable foundation;
3) fluorescence probe has very strong specificity, only combines the chromosome of specific site, high specificity;
4) fluorescence in situ hybridization technique is used, fluorescence signal is very clear under the microscope, and sensitivity is very high;
5) smear can be processed into rapidly after obtaining bone marrow cell, and result can be typically gone out in 2-5 days.
Brief description of the drawings
Fig. 1 is FISH normal cell schematic diagrames, 1, orange, 2, green.
Fig. 2 is FISH abnormal cells, 1, orange, 2, green, 3, fusion.
Embodiment
The present invention is described in further details with specific embodiment below, but the present invention is not only limited in detail below in fact Apply example.
Embodiment provided below is simultaneously not used to the scope that the limitation present invention is covered, described step nor with To limit its execution sequence.Those skilled in the art do conspicuously improved with reference to existing common knowledge to the present invention, also fall Enter within the protection domain of application claims.
Embodiment one
A kind of hypotype Ph-likeALL detection method, comprises the following steps:
1)Ethanol solution, pretreatment fluid, washing lotion and enzyme buffer liquid are prepared respectively, put 2 DEG C of -8 DEG C of condition of nitrogen gas storages;The ethanol The volume fraction of solution is 70 ~ 85%;The pretreatment fluid is 0.9 ~ 1.1mol/L sodium thiocyanate solution;The washing lotion by with The component composition of lower percetage by weight:Sodium chloride 1.7 ~ 1.8%, sodium citrate 0.8 ~ 1%, Nonidet P40 0.2 ~ 0.4%, surplus is water;The enzyme buffer liquid is 0.009 ~ 0.011mol/L watery hydrochloric acid;
2)Fluorescence probe dissolves:Jia 10 into probe tube ~ 20 μ l water, add 150 ~ 200 μ l hybridization solutions, 30 ~ 60s of ultrasonic dissolution, Obtain probe solution;Totally 12 groups of the fluorescence probe, respectively ABL1, ABL2, CSF1R, PDGFRB, CRLF2, JAK2, EPOR, IL2RB, NTRK3, PTK2B, TSLP and TYK2;
3)Bone marrow cell is solidified, is applied on slide, by pretreatment, smear is made;It is described be cured as test tube of hepari processing or Handled through EDTA- sodium acetates;
4)By probe solution pre-temperature to room temperature, whirlpool is mixed, and centrifuges 2 ~ 3s, and the probe solution for taking 5 ~ 15 μ l to mix is added drop-wise to hybridization Region, covered is sealed with mounting glue;
5)Setting program:First 70 ~ 80 DEG C are denatured 5 ~ 10 minutes, and then 35 ~ 40 DEG C hybridize 16 ~ 18h;
6)Mounting glue is removed, 1 ~ 5min washes away cover glass in the room temperature washing lotion being placed in Kao Pulin cylinders, take out smear, with warmed-up 1 ~ 3min is rinsed to 72 ~ 74 DEG C of washing lotions, then 1 ~ 3min, lucifuge natural air drying are rinsed with the ethanol solution of room temperature 65 ~ 75%;
7)Dropwise addition redyes liquid to hybridising region, and covered is put -25 ~ -15 DEG C of dark places and redyed more than 20 minutes;It is described to redye Liquid is made up of the component of following parts by weight:5 ~ 7 parts of gram staining liquid, 1 ~ 3 part of magnesium chloride, 0.2 ~ 0.6 part of citric acid, fluorescence 0.5 ~ 0.7 part of element, 0.1 ~ 0.3 part of sodium alginate;
8)Sample is scanned using object lens, determines whether sample has heterogeneity.
The step 2)Fluorescence probe dissolving also comprises the following steps:Probe bottom of the tube and tube wall are rinsed with liquid-transfering gun, is shaken 20 ~ 40s of mixing is swung, 20 ~ 40s is centrifuged, 35 ~ 40 DEG C of water-bath insulations is put and dissolves 5 ~ 15 minutes;Repeat said process 2 ~ 3 times, will match somebody with somebody The probe solution made is standby or packing frost is kept in dark place.
The step 6)Kao Pulin cylinders are additionally operable to hold pretreatment fluid, washing lotion and enzyme buffer liquid, and the washing lotion is preheated to 72 ~ 74 DEG C, the pretreatment fluid is preheated to 75 ~ 85 DEG C, the enzyme buffer liquid is preheated to 36 ~ 38 DEG C.
The pH value of the washing lotion at room temperature is 7.0 ± 0.2;The enzyme buffer liquid is 0.01mol/L watery hydrochloric acid, at room temperature PH value be 2.0 ± 0.2.
The step 3)Pretreatment comprises the following steps:a)By 60 ~ 70 DEG C of 5 ~ 10min of preheating of smear, dewaxed with waxdip saturating Bright liquid is dewaxed 2 10 ~ 20min every time, and 23 ~ 5min every time are dehydrated with absolute ethyl alcohol;The waxdip dewaxing transparent liquid is isomery Alkane type;b)Gradient rehydration, each 0.5 ~ 2min in 85% ethanol, 70% ethanol, purified water, suck residual solution successively;c)Put 20 ~ 40min is incubated in 75 ~ 85 DEG C of pretreatment fluid is had been preheated with, takes out and 1 ~ 2min is soaked in purified water, suck remnants Solution;d)Take 40 ~ 60mg pepsin dry powder to be dissolved in be pre-heated in 36 ~ 38 DEG C of enzyme buffer liquid, immersion digestion 20 ~ 30min;e)1 ~ 2min is soaked in purified water, successively the serial dehydration in 85% ethanol, 70% ethanol, purified water, each 0.5 ~ 2min, drying for standby.
The step c)Described in pretreatment fluid be 0.9 ~ 1.1mol/L sodium thiocyanate solution.
The enzyme buffer liquid is 0.01mol/L watery hydrochloric acid, and pH value at room temperature is 2.0 ± 0.2.
There is the feature of heterogeneity in the result of the scanning to have fused cell.
Embodiment two
A kind of hypotype Ph-likeALL detection method, comprises the following steps:
1)Ethanol solution, pretreatment fluid, washing lotion and enzyme buffer liquid are prepared respectively, put 2 DEG C of -8 DEG C of condition of nitrogen gas storages;The ethanol The volume fraction of solution is 70 ~ 85%;The pretreatment fluid is 0.9 ~ 1.1mol/L sodium thiocyanate solution;The washing lotion by with The component composition of lower percetage by weight:Sodium chloride 1.7 ~ 1.8%, sodium citrate 0.8 ~ 1%, Nonidet P40 0.2 ~ 0.4%, surplus is water;The enzyme buffer liquid is 0.009 ~ 0.011mol/L watery hydrochloric acid;
2)Fluorescence probe dissolves:Jia 10 into probe tube ~ 20 μ l water, add 150 ~ 200 μ l hybridization solutions, 30 ~ 60s of ultrasonic dissolution, Obtain probe solution;Totally 12 groups of the fluorescence probe, respectively ABL1, ABL2, CSF1R, PDGFRB, CRLF2, JAK2, EPOR, IL2RB, NTRK3, PTK2B, TSLP and TYK2;
3)Bone marrow cell is solidified, is applied on slide, by pretreatment, smear is made;It is described be cured as test tube of hepari processing or Handled through EDTA- sodium acetates;
4)By probe solution pre-temperature to room temperature, whirlpool is mixed, and centrifuges 2 ~ 3s, and the probe solution for taking 5 ~ 15 μ l to mix is added drop-wise to hybridization Region, covered is sealed with mounting glue;
5)Setting program:First 70 ~ 80 DEG C are denatured 5 ~ 10 minutes, and then 35 ~ 40 DEG C hybridize 16 ~ 18h;
6)Mounting glue is removed, 1 ~ 5min washes away cover glass in the room temperature washing lotion being placed in Kao Pulin cylinders, take out smear, with warmed-up 1 ~ 3min is rinsed to 72 ~ 74 DEG C of washing lotions, then 1 ~ 3min, lucifuge natural air drying are rinsed with the ethanol solution of room temperature 65 ~ 75%;
7)Dropwise addition redyes liquid to hybridising region, and covered is put -25 ~ -15 DEG C of dark places and redyed more than 20 minutes;It is described to redye Liquid is made up of the component of following parts by weight:5 ~ 7 parts of gram staining liquid, 1 ~ 3 part of magnesium chloride, 0.2 ~ 0.6 part of citric acid, fluorescence 0.5 ~ 0.7 part of element, 0.1 ~ 0.3 part of sodium alginate;
8)Sample is scanned using object lens, determines whether sample has heterogeneity.
The step 2)Fluorescence probe dissolving also comprises the following steps:Probe bottom of the tube and tube wall are rinsed with liquid-transfering gun, is shaken 20 ~ 40s of mixing is swung, 20 ~ 40s is centrifuged, 35 ~ 40 DEG C of water-bath insulations is put and dissolves 5 ~ 15 minutes;Repeat said process 2 ~ 3 times, will match somebody with somebody The probe solution made is standby or packing frost is kept in dark place.
The step 6)Kao Pulin cylinders are additionally operable to hold pretreatment fluid, washing lotion and enzyme buffer liquid, and the washing lotion is preheated to 72 ~ 74 DEG C, the pretreatment fluid is preheated to 75 ~ 85 DEG C, the enzyme buffer liquid is preheated to 36 ~ 38 DEG C.
The pH value of the washing lotion at room temperature is 7.0 ± 0.2;The enzyme buffer liquid is 0.01mol/L watery hydrochloric acid, at room temperature PH value be 2.0 ± 0.2.
The step 3)Pretreatment comprises the following steps:a)By 60 ~ 70 DEG C of 5 ~ 10min of preheating of smear, dewaxed with waxdip saturating Bright liquid is dewaxed 2 10 ~ 20min every time, and 23 ~ 5min every time are dehydrated with absolute ethyl alcohol;The waxdip dewaxing transparent liquid is isomery Alkane type;b)Gradient rehydration, each 0.5 ~ 2min in 85% ethanol, 70% ethanol, purified water, suck residual solution successively;c)Put 20 ~ 40min is incubated in 75 ~ 85 DEG C of pretreatment fluid is had been preheated with, takes out and 1 ~ 2min is soaked in purified water, suck remnants Solution;d)Take 40 ~ 60mg pepsin dry powder to be dissolved in be pre-heated in 36 ~ 38 DEG C of enzyme buffer liquid, immersion digestion 20 ~ 30min;e)1 ~ 2min is soaked in purified water, successively the serial dehydration in 85% ethanol, 70% ethanol, purified water, each 0.5 ~ 2min, drying for standby.
The step c)Described in pretreatment fluid be 0.9 ~ 1.1mol/L sodium thiocyanate solution.
The enzyme buffer liquid is 0.01mol/L watery hydrochloric acid, and pH value at room temperature is 2.0 ± 0.2.
There is the feature of heterogeneity in the result of the scanning to have fused cell
Embodiment three
A kind of hypotype Ph-likeALL detection method, comprises the following steps:
1)Ethanol solution, pretreatment fluid, washing lotion and enzyme buffer liquid are prepared respectively, put 2 DEG C of -8 DEG C of condition of nitrogen gas storages;The ethanol The volume fraction of solution is 70 ~ 85%;The pretreatment fluid is 0.9 ~ 1.1mol/L sodium thiocyanate solution;The washing lotion by with The component composition of lower percetage by weight:Sodium chloride 1.7 ~ 1.8%, sodium citrate 0.8 ~ 1%, Nonidet P40 0.2 ~ 0.4%, surplus is water;The enzyme buffer liquid is 0.009 ~ 0.011mol/L watery hydrochloric acid;
2)Fluorescence probe dissolves:Jia 10 into probe tube ~ 20 μ l water, add 150 ~ 200 μ l hybridization solutions, 30 ~ 60s of ultrasonic dissolution, Obtain probe solution;Totally 12 groups of the fluorescence probe, respectively ABL1, ABL2, CSF1R, PDGFRB, CRLF2, JAK2, EPOR, IL2RB, NTRK3, PTK2B, TSLP and TYK2;
3)Bone marrow cell is solidified, is applied on slide, by pretreatment, smear is made;It is described be cured as test tube of hepari processing or Handled through EDTA- sodium acetates;
4)By probe solution pre-temperature to room temperature, whirlpool is mixed, and centrifuges 2 ~ 3s, and the probe solution for taking 5 ~ 15 μ l to mix is added drop-wise to hybridization Region, covered is sealed with mounting glue;
5)Setting program:First 70 ~ 80 DEG C are denatured 5 ~ 10 minutes, and then 35 ~ 40 DEG C hybridize 16 ~ 18h;
6)Mounting glue is removed, 1 ~ 5min washes away cover glass in the room temperature washing lotion being placed in Kao Pulin cylinders, take out smear, with warmed-up 1 ~ 3min is rinsed to 72 ~ 74 DEG C of washing lotions, then 1 ~ 3min, lucifuge natural air drying are rinsed with the ethanol solution of room temperature 65 ~ 75%;
7)Dropwise addition redyes liquid to hybridising region, and covered is put -25 ~ -15 DEG C of dark places and redyed more than 20 minutes;It is described to redye Liquid is made up of the component of following parts by weight:5 ~ 7 parts of gram staining liquid, 1 ~ 3 part of magnesium chloride, 0.2 ~ 0.6 part of citric acid, fluorescence 0.5 ~ 0.7 part of element, 0.1 ~ 0.3 part of sodium alginate;
8)Sample is scanned using object lens, determines whether sample has heterogeneity.
The step 2)Fluorescence probe dissolving also comprises the following steps:Probe bottom of the tube and tube wall are rinsed with liquid-transfering gun, is shaken 20 ~ 40s of mixing is swung, 20 ~ 40s is centrifuged, 35 ~ 40 DEG C of water-bath insulations is put and dissolves 5 ~ 15 minutes;Repeat said process 2 ~ 3 times, will match somebody with somebody The probe solution made is standby or packing frost is kept in dark place.
The step 6)Kao Pulin cylinders are additionally operable to hold pretreatment fluid, washing lotion and enzyme buffer liquid, and the washing lotion is preheated to 72 ~ 74 DEG C, the pretreatment fluid is preheated to 75 ~ 85 DEG C, the enzyme buffer liquid is preheated to 36 ~ 38 DEG C.
The pH value of the washing lotion at room temperature is 7.0 ± 0.2;The enzyme buffer liquid is 0.01mol/L watery hydrochloric acid, at room temperature PH value be 2.0 ± 0.2.
The step 3)Pretreatment comprises the following steps:a)By 60 ~ 70 DEG C of 5 ~ 10min of preheating of smear, dewaxed with waxdip saturating Bright liquid is dewaxed 2 10 ~ 20min every time, and 23 ~ 5min every time are dehydrated with absolute ethyl alcohol;The waxdip dewaxing transparent liquid is isomery Alkane type;b)Gradient rehydration, each 0.5 ~ 2min in 85% ethanol, 70% ethanol, purified water, suck residual solution successively;c)Put 20 ~ 40min is incubated in 75 ~ 85 DEG C of pretreatment fluid is had been preheated with, takes out and 1 ~ 2min is soaked in purified water, suck remnants Solution;d)Take 40 ~ 60mg pepsin dry powder to be dissolved in be pre-heated in 36 ~ 38 DEG C of enzyme buffer liquid, immersion digestion 20 ~ 30min;e)1 ~ 2min is soaked in purified water, successively the serial dehydration in 85% ethanol, 70% ethanol, purified water, each 0.5 ~ 2min, drying for standby.
The step c)Described in pretreatment fluid be 0.9 ~ 1.1mol/L sodium thiocyanate solution.
The enzyme buffer liquid is 0.01mol/L watery hydrochloric acid, and pH value at room temperature is 2.0 ± 0.2.
There is the feature of heterogeneity in the result of the scanning to have fused cell.

Claims (10)

1. a kind of hypotype Ph-likeALL detection method, it is characterised in that comprise the following steps:
1)Ethanol solution, pretreatment fluid, washing lotion and enzyme buffer liquid are prepared respectively, put 2 DEG C of -8 DEG C of condition of nitrogen gas storages;
2)Fluorescence probe dissolves:Jia 10 into probe tube ~ 20 μ l water, add 150 ~ 200 μ l hybridization solutions, 30 ~ 60s of ultrasonic dissolution, Obtain probe solution;
3)Bone marrow cell is solidified, is applied on slide, by pretreatment, smear is made;It is described be cured as test tube of hepari processing or Handled through EDTA- sodium acetates;
4)By probe solution pre-temperature to room temperature, whirlpool is mixed, and centrifuges 2 ~ 3s, and the probe solution for taking 5 ~ 15 μ l to mix is added drop-wise to hybridization Region, covered is sealed with mounting glue;
5)Setting program:First 70 ~ 80 DEG C are denatured 5 ~ 10 minutes, and then 35 ~ 40 DEG C hybridize 16 ~ 18h;
6)Mounting glue is removed, 1 ~ 5min washes away cover glass in the room temperature washing lotion being placed in Kao Pulin cylinders, take out smear, with warmed-up 1 ~ 3min is rinsed to 72 ~ 74 DEG C of washing lotions, then 1 ~ 3min, lucifuge natural air drying are rinsed with the ethanol solution of room temperature 65 ~ 75%;
7)Dropwise addition redyes liquid to hybridising region, and covered is put -25 ~ -15 DEG C of dark places and redyed more than 20 minutes;It is described to redye Liquid is made up of the component of following parts by weight:5 ~ 7 parts of gram staining liquid, 1 ~ 3 part of magnesium chloride, 0.2 ~ 0.6 part of citric acid, fluorescence 0.5 ~ 0.7 part of element, 0.1 ~ 0.3 part of sodium alginate;
8)Sample is scanned using object lens, determines whether sample has heterogeneity.
2. hypotype Ph-likeALL according to claim 1 detection method, it is characterised in that the body of the ethanol solution Fraction is 70 ~ 85%;The pretreatment fluid is 0.9 ~ 1.1mol/L sodium thiocyanate solution;The washing lotion is by following weight hundred The component composition of fraction:Sodium chloride 1.7 ~ 1.8%, sodium citrate 0.8 ~ 1%, Nonidet P40 0.2 ~ 0.4%, surplus is Water;The enzyme buffer liquid is 0.009 ~ 0.011mol/L watery hydrochloric acid.
3. hypotype Ph-likeALL according to claim 1 detection method, it is characterised in that the fluorescence probe totally 12 Group, respectively ABL1, ABL2, CSF1R, PDGFRB, CRLF2, JAK2, EPOR, IL2RB, NTRK3, PTK2B, TSLP and TYK2。
4. hypotype Ph-likeALL according to claim 1 detection method, it is characterised in that the step 2)Fluorescence is visited Pin dissolving also comprises the following steps:Probe bottom of the tube and tube wall are rinsed with liquid-transfering gun, vibration mixes 20 ~ 40s, centrifuges 20 ~ 40s, 35 ~ 40 DEG C of water-bath insulations are put to dissolve 5 ~ 15 minutes;Said process 2 ~ 3 times is repeated, by the probe solution prepared is standby or packing Frost is kept in dark place.
5. hypotype Ph-likeALL according to claim 1 detection method, it is characterised in that the step 6)Kao Pulin Cylinder is additionally operable to hold pretreatment fluid, washing lotion and enzyme buffer liquid, and the washing lotion is preheated into 72 ~ 74 DEG C, and the pretreatment fluid is pre- The enzyme buffer liquid is preheated to 36 ~ 38 DEG C by heat to 75 ~ 85 DEG C.
6. hypotype Ph-likeALL according to claim 1 detection method, it is characterised in that the step 3)Pretreatment Comprise the following steps:a)By 60 ~ 70 DEG C of smear, 5 ~ 10min of preheating, dewaxed 2 10 ~ 20min every time with waxdip dewaxing transparent liquid, 23 ~ 5min every time are dehydrated with absolute ethyl alcohol;b)The gradient rehydration in 85% ethanol, 70% ethanol, purified water successively, each 0.5 ~ 2min, sucks residual solution;c)20 ~ 40min of insulation in the pretreatment fluid for have been preheated with 75 ~ 85 DEG C is placed on, is taken out in purifying 1 ~ 2min is soaked in water, residual solution is sucked;d)Take 40 ~ 60mg pepsin dry powder to be dissolved in and be pre-heated to 36 ~ 38 DEG C of enzyme In buffer solution, 20 ~ 30min of immersion digestion;e)1 ~ 2min is soaked in purified water, successively in 85% ethanol, 70% ethanol, purified water Middle serial dehydration, each 0.5 ~ 2min, drying for standby.
7. hypotype Ph-likeALL according to claim 8 detection method, it is characterised in that the step a)Waxdip takes off Wax transparent liquid is isoparaffin type.
8. hypotype Ph-likeALL according to claim 8 detection method, it is characterised in that the step c)Described in Pretreatment fluid is 0.9 ~ 1.1mol/L sodium thiocyanate solution.
9. hypotype Ph-likeALL according to claim 8 detection method, it is characterised in that the enzyme buffer liquid is 0.01mol/L watery hydrochloric acid, pH value at room temperature is 2.0 ± 0.2.
10. hypotype Ph-likeALL according to claim 1 detection method, it is characterised in that the result of the scanning In have the feature of heterogeneity to there is fused cell.
CN201710462205.5A 2017-06-19 2017-06-19 A kind of hypotype Ph likeALL detection method Pending CN107058593A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710462205.5A CN107058593A (en) 2017-06-19 2017-06-19 A kind of hypotype Ph likeALL detection method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710462205.5A CN107058593A (en) 2017-06-19 2017-06-19 A kind of hypotype Ph likeALL detection method

Publications (1)

Publication Number Publication Date
CN107058593A true CN107058593A (en) 2017-08-18

Family

ID=59594323

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710462205.5A Pending CN107058593A (en) 2017-06-19 2017-06-19 A kind of hypotype Ph likeALL detection method

Country Status (1)

Country Link
CN (1) CN107058593A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107227359A (en) * 2017-06-19 2017-10-03 福建万科药业有限公司 A kind of hypotype Ph likeALL detection kit and its detection method
CN110218790A (en) * 2019-05-10 2019-09-10 广州安必平医药科技股份有限公司 For detecting probe chip, kit and its application of the rearrangement of Ph-like ALL related gene
CN114181995A (en) * 2021-12-10 2022-03-15 山东博思源生物技术有限公司 Sample pre-hybridization pretreatment reagent and use method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102978279A (en) * 2012-09-27 2013-03-20 中国医学科学院血液病医院(血液学研究所) Gene probe composition and kit for acute lymphocytic leukemia detection
WO2013090419A1 (en) * 2011-12-12 2013-06-20 Stc.Unm Gene expression signatures for detection of underlying philadelphia chromosome-like (ph-like) events and therapeutic targeting in leukemia
CN103409505A (en) * 2013-06-26 2013-11-27 武汉康录生物技术有限公司 FISH (fluorescence in situ hybridization) probe, kit and detection method for detecting BCR/ABL fusion gene free from repetitive sequence
CN105018598A (en) * 2015-06-05 2015-11-04 厦门艾德生物医药科技有限公司 FISH pretreatment method and pretreatment fluid for FFPE sample
CN106282357A (en) * 2016-08-30 2017-01-04 武汉康圣达医学检验所有限公司 A kind of method detecting Ph like related gene position of fusion
CN106480204A (en) * 2016-11-08 2017-03-08 南通大学附属医院 A kind of fluorescence in-situ hybridization method of improvement and its application

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013090419A1 (en) * 2011-12-12 2013-06-20 Stc.Unm Gene expression signatures for detection of underlying philadelphia chromosome-like (ph-like) events and therapeutic targeting in leukemia
CN102978279A (en) * 2012-09-27 2013-03-20 中国医学科学院血液病医院(血液学研究所) Gene probe composition and kit for acute lymphocytic leukemia detection
CN103409505A (en) * 2013-06-26 2013-11-27 武汉康录生物技术有限公司 FISH (fluorescence in situ hybridization) probe, kit and detection method for detecting BCR/ABL fusion gene free from repetitive sequence
CN105018598A (en) * 2015-06-05 2015-11-04 厦门艾德生物医药科技有限公司 FISH pretreatment method and pretreatment fluid for FFPE sample
CN106282357A (en) * 2016-08-30 2017-01-04 武汉康圣达医学检验所有限公司 A kind of method detecting Ph like related gene position of fusion
CN106480204A (en) * 2016-11-08 2017-03-08 南通大学附属医院 A kind of fluorescence in-situ hybridization method of improvement and its application

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
孙燕: "《微生物学实验指导》", 31 August 2015, 陕西师范大学出版总社 *
王会: "母源性微嵌合体与胆道闭锁发病机制的相关性研究", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 *
王晓雪等: "Ph样急性淋巴细胞白血病的研究进展", 《现代肿瘤医学》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107227359A (en) * 2017-06-19 2017-10-03 福建万科药业有限公司 A kind of hypotype Ph likeALL detection kit and its detection method
CN110218790A (en) * 2019-05-10 2019-09-10 广州安必平医药科技股份有限公司 For detecting probe chip, kit and its application of the rearrangement of Ph-like ALL related gene
CN114181995A (en) * 2021-12-10 2022-03-15 山东博思源生物技术有限公司 Sample pre-hybridization pretreatment reagent and use method thereof

Similar Documents

Publication Publication Date Title
Xie et al. Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
CN107058593A (en) A kind of hypotype Ph likeALL detection method
CN104379740A (en) Novel fgfr3 fusion product
CN103033409B (en) The histocyte colouring method improved and application thereof
CN109220911B (en) Application of glucose and ethanol in synergistic regulation and control of cardiovascular development of zebra fish
CN110384800A (en) Application of the LncRNA XLOC_075168 in the drug that preparation promotes angiogenesis
CN105200152B (en) Applications of the long-chain non-coding RNA LOC553103 on nasopharyngeal carcinoma prognosis preparation is prepared
Holt Local protein accumulation during gene activation: I. Quantitative measurements on dye binding capacity at subsequent stages of puff formation in Drosophila hydei
Markman Regional differences in isotopic labelling of nucleic acid and protein in early sea urchin development: an autoradiographic study
Gong et al. Nitazoxanide induced myocardial injury in zebrafish embryos by activating oxidative stress response
CN104878011B (en) Applications of the long-chain non-coding RNA AFAP1-AS1 on preparing breast cancer real time fluorescent quantitative auxiliary diagnosis preparation
CN106636376A (en) Nucleic acid and kit for detecting human ROS1 fusion genes and application method of kit
CN110484614A (en) Application of the inhibitor of LncRNA XLOC_057528 in the drug that preparation promotes angiogenesis
CN107177677B (en) A kind of probe groups, kit and its application for being used to detect TERT gene breaks
CN102899411A (en) G6PD deficiency disease gene detection kit
Li et al. Identification of ADAM10 and ADAM17 with potential roles in the spermatogenesis of the Chinese mitten crab, Eriocheir sinensis
CN104878010B (en) Applications of the long-chain non-coding RNA AFAP1-AS1 on preparing Computer-aided Diagnosis of Breast Cancer and Index for diagnosis preparation
WO2023104059A1 (en) Circulating tumor cell detection material, detector and detection method
CN110327341A (en) Application of the ACSS2 inhibitor in preparation prevention and/or treatment medicine for treating diabetic nephropathy
CN109975095A (en) A kind of pretreatment liquid and pre-treating method of fluorescence in situ hybridization
CN107227359A (en) A kind of hypotype Ph likeALL detection kit and its detection method
Wei et al. Ablating Lgr5-expressing prostatic stromal cells activates the ERK-mediated mechanosensory signaling and disrupts prostate tissue homeostasis
CN105267987B (en) Applications of the long-chain non-coding RNA LOC553103 on stomach cancer cell inhibitor is prepared
CN107583052A (en) Applications of the 5p of miR 6734 in Luminal type breast cancer diagnosis instruments are prepared
CN106511368B (en) The application of the siRNA of long-chain non-coding RNA LINC00152 and inhibitory preparation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170818

RJ01 Rejection of invention patent application after publication